RFC
AGRX

Russell Frank Company’s Agile Therapeutics AGRX Stock Holding History

Russell Frank Company’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15
Closed -$254K – 3074
2015
Q2 		$254K Buy
+15
New +$320K ﹤0.01% 2759

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Russell Frank Company's AGRX Position: Q3 2015 in Review

Russell Frank Company sold out of Agile Therapeutics (AGRX) in Q3 2015, closing a stake of 15 shares — an estimated $254K sold.

Russell Frank Company first reported a position in AGRX in Q2 2015 and held it in 1 quarter. The position peaked at $254K in Q2 2015. 45 funds tracked by Wall St. Rank hold AGRX as of Q3 2015.

  • Russell Frank Company reported no remaining Agile Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Russell Frank Company sold 15 Agile Therapeutics shares in Q3 2015, an estimated $254K.
  • Russell Frank Company first reported a position in Agile Therapeutics in Q2 2015 and held it in 1 quarter.
  • Russell Frank Company's Agile Therapeutics position peaked at $254K in Q2 2015.
  • 45 funds tracked by Wall St. Rank held Agile Therapeutics as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.